4//SEC Filing
Hamm Robert A 4
Accession 0001127602-10-006333
CIK 0000875045other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:12 PM ET
Size
10.6 KB
Accession
0001127602-10-006333
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Award
Common Stock
2010-02-24+9,306→ 32,252.41 total - Tax Payment
Common Stock
2010-02-24$55.29/sh−985$54,461→ 31,267.41 total - Tax Payment
Common Stock
2010-02-24$55.29/sh−996$55,069→ 30,271.41 total - Award
Restricted Stock Unit
2010-02-23+48,916→ 48,916 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (48,916 underlying)
Footnotes (2)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F2]There is no conversion or exercise price for this stock unit.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001335018
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:12 PM ET
- Size
- 10.6 KB